Medical/Pharmaceuticals
Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept
BRIDGEWATER, N.J. and BENGALURU, India, July 24, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion r...
2023-07-24 18:30
1643
Apollo leads India's Solid Multi-Organ Transplantation with over 23000 transplants, establishes global leadership
Apollo performs the highest number of solid organ transplants in the world per year NEW DELHI, July 24, 2023 /PRNewswire/ -- Apollo, the world's largest vertically integrated healthcare provider, has achieved a momentous feat by completing 23,000 transplants. The Apollo Transplant Program stands...
2023-07-24 14:30
1736
Project Matty: Revolutionizing Care for Children with Autism and ADHD Through AI
SINGAPORE, July 24, 2023 /PRNewswire/ -- Project Matty, a pioneering digital health solution, has been launched by a dedicated mother of an ADHD-diagnosed child and Dr.Pamela Lim, a clinical psychology doctor. Both inspired by their personal experiences and united by their commitment to improve t...
2023-07-24 12:11
2611
BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears
* Vaccination and Screening Form a Virtuous Cycle to Combat Cervical Cancer HONG KONG, July 24, 2023 /PRNewswire/ -- To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervical Cancer Awareness Report today....
2023-07-24 10:30
2546
ConcertAI's TeraRecon Expands Relationship with Change Healthcare for Advanced Visualization Offering in Australia
The expanded agreement allows providers to locally acquire TeraRecon's solutions CAMBRIDGE, Mass., July 24, 2023 /PRNewswire/ -- Advanced visualization and AI leader TeraRecon, a ConcertAI company, is excited to announce an expansion of its reseller and service agreement inAustralia with Change H...
2023-07-24 04:30
2051
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
SUZHOU, China, July 22, 2023 /PRNewswire/ -- Last month, the American Society
for Artificial Internal Organs (ASAIO) 68th Annual Meeting
2023-07-22 18:17
6446
Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation
* Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients inEurope die annually from the disease² * If approved by the European Commission, ORSERDU would be the first an...
2023-07-21 23:44
5722
Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA
SAN DIEGO, July 21, 2023 /PRNewswire/ -- Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to aid in the selection of patients with newly diagnosedFLT3-ITD positive acute myeloid leukemia (AML) who may...
2023-07-21 18:00
2878
Saphnelo now available in Malaysia as an add-on treatment for adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE)
KUALA LUMPUR, Malaysia, July 21, 2023 /PRNewswire/ -- AstraZeneca's Saphnelo ( anifrolumab) has now become available as add-on treatment for adult patients in Malaysia with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE) following insufficient response to sta...
2023-07-21 10:00
2363
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib Clinical Study
HANGZHOU, China, July 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first patient with atopic dermatitis in a Phase Ib clinical trial of its innovative drug LNK0100...
2023-07-21 08:00
2938
ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED AT ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE
AMSTERDAM, July 20, 2023 /PRNewswire/ -- New research reported at the Alzheimer's Association International Conference® (AAIC®) 2023 covered the breadth of Alzheimer's disease and dementia research, including advancements in treatment, early and accurate diagnosis, and our understanding of risk f...
2023-07-20 21:01
2629
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs
WATERTOWN, Mass., July 20, 2023 /PRNewswire/ -- Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases. Riparian today announced it has entered into an exclusive license agreement and research a...
2023-07-20 19:15
2409
PolyU awarded RGC Strategic Topics Grant to address societal needs in mental healthcare
HONG KONG, July 20, 2023 /PRNewswire/ -- The Hong Kong Polytechnic University (PolyU) has received funding support from the Strategic Topics Grant (STG) 2023/24 of the Research Grants Council (RGC) for a health technology project aimed at promoting a new paradigm shift with creation of an integra...
2023-07-20 19:07
2175
SayHeart: The AI Powerhouse Decoding Health Complexity
KUALA LUMPUR, Malaysia and SINGAPORE, July 20, 2023 /PRNewswire/ -- SayHeart, an inventive start-up, is set to redefine the healthcare industry with its AI-powered technology that simplifies convoluted health data into comprehensible narratives. Employing Generative AI, SayHeart has devised an...
2023-07-20 19:03
2258
2023 Brain Health and Disability Webinar: Leave No One Behind
LONDON, July 20, 2023 /PRNewswire/ -- This year marks the 10th Anniversary of World Brain Day, hosted annually onJuly 22 by the World Federation of Neurology (WFN). This year's World Brain Day will bring together expert neurologists, advocates and patients to share vital resources and information...
2023-07-20 14:00
614
Gannex Announces the Completion of Patient Enrollment for Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis
-- Gannex is expected to release topline data of the Phase II clinical trial by the end of 2023 SHANGHAI, July 20, 2023 /PRNewswire/ -- Gannex Pharma Co., Ltd. ("Gannex"), a wholly-owned company of Ascletis Pharma Inc. (HKEX:1672) announces today the completion of enrollment of 98 patients with ...
2023-07-20 08:10
2617
Harrison.ai Welcomes Robyn Denholm As Board Director
SYDNEY, July 20, 2023 /PRNewswire/ -- Global technology leader Robyn Denholm
has been announced as the newest member of theHarrison.ai
2023-07-20 05:00
1990
SIMPLE FINGER PRICK TEST EXEMPLIFIES ADVANCES IN ALZHEIMER'S DISEASE BLOOD TESTS
Key Takeaways: * Results from a simple, finger prick blood test are promising and may help detect Alzheimer's at home or in the doctor's office. * A blood test was more than 80% accurate in identifying Alzheimer's-related changes — significantly better than doctors in the study who did not ha...
2023-07-19 20:00
2271
Significantly Reduce Manufacturing Cost and Increased Local Production: SCG Cell Therapy Opens State-of-the-art Cell Therapy Manufacturing Facility and R&D Centre in Singapore
* SCG Cell Therapy celebrates the opening of its new Cell Therapy Manufacturing Facility and R&D Centre, launching a new first-of-its-kind automatic cell therapy manufacturing system in Singapore, pioneeringSingapore's Manufacturing 2030 Vision. * Facility will substantially increase local ...
2023-07-19 19:20
3488
GHA Accreditation Helps Position Dr. Sulaiman Al-Habib Hospital in Al Khobar as a Trusted Destination for Medical Travel
PALM BEACH GARDENS, Fla., July 19, 2023 /PRNewswire/ -- In a significant achievement that firmly underscores its commitment to the highest standards of healthcare, Dr. Sulaiman AL-Habib Hospital in AL Khobar, Saudi Arabia, has been awarded the distinguished Accreditation for Medical Travel Servic...
2023-07-19 18:00
2372
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8546
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7700